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Background:  Current guidelines define severe aortic stenosis as a valve area (AVA) < 1 cm2, mean gradient (MG) > 40 mmHg, peak velocity 
(Vmax) > 4 m/sec, and dimensionless index (DI) <0.25. Important clinical decisions are made based on these parameters.
Methods:  From 2006 to 2010, we identified consecutive patients with LVEF > 50%, MG > 20mm Hg, ≤ mild aortic regurgitation, heart rate 60-90; 
and divided them in 2 groups: patients with “normal” LVOT diameter = 2.0 cm and patients with “large” LVOT > 2.3 cm.
Results:  790 patients had LVOT = 2.0 (group 1) and 1151 LVOT > 2.3 (group 2). Group 1 comprised 24% males (93% group 2), age 75± 15 (70± 
15 group 2), LVOT 2.0 (2.5± 0.1 group 2), LVOT TVI 27± 5 (23± 4 group 2), stroke volume index (SVI) 47± 9 (53± 11 group 2), SVI <35 (paradoxical 
low output) in 10% (2% group 2), cardiac index (CI) 3.3 ±0.73 (3.73±0.89 group 2), bicuspid aortic valve 3% (13% group 2), all p<0.001. MG 
was 36± 14 and 35± 14 for groups 1 and 2, respectively (p=0.2). Vmax was 3.9± 0.7 and 3.8 ± 0.6 for groups 1 and 2, respectively (p=0.08). AVA 
was 0.99±0.2 and 1.37±0.4 for groups 1 and 2, respectively (p<0.0001). AVA indexed for BSA was 0.55±0.17 and 0.66±0.24 for groups 1 and 2, 
respectively (p<0.0001). AVA of 1 cm2 corresponded to MG of 33 and 40 for groups 1 and 2, respectively (p<0.0001), DI 0.32 and 0.22 for groups 1 
and 2, respectively (p<0.0001) and Vmax 3.7 and 4.0 for groups 1 and 2, respectively (p<0.0001). For AVA of 0.75 cm2, Vmax was 4.1, DI was 0.24, 
MG was 42 for group 1 and Vmax was 4.2, DI was 0.12 and MG was 44 for group 2.
Conclusions:  For patients with LVOT of 2.0 cm, there is significant discrepancy between AVA and other severity parameters with guideline-
recommended “severe” parameters corresponding to AVA of 0.75 cm2. For patients with LVOT > 2.3 cm, SVI and CI are systematically larger despite 
a lower LVOT TVI, likely resulting in larger AVA despite similar MG and Vmax as compared to LVOT of 2.0 cm. In LVOT > 2.3 cm patients, severity 
parameters are systematically higher for any given AVA, DI being the most variable/ unreliable. Vmax appears to be the most stable/reliable severity 
parameter for all LVOT diameters studied.
